| Literature DB >> 29382850 |
Milana Kokosar1, Anna Benrick1,2, Alexander Perfilyev3, Emma Nilsson3, Thomas Källman4, Claes Ohlsson5, Charlotte Ling3, Elisabet Stener-Victorin6.
Abstract
A single bout of electroacupuncture results in muscle contractions and increased whole body glucose uptake in women with polycystic ovary syndrome (PCOS). Women with PCOS have transcriptional and epigenetic alterations in the adipose tissue and we hypothesized that electroacupuncture induces epigenetic and transcriptional changes to restore metabolic alterations. Twenty-one women with PCOS received a single bout of electroacupuncture, which increased the whole body glucose uptake. In subcutaneous adipose tissue biopsies, we identified treatment-induced expression changes of 2369 genes (Q < 0.05) and DNA methylation changes of 7055 individual genes (Q = 0.11). The largest increase in expression was observed for FOSB (2405%), and the largest decrease for LOC100128899 (54%). The most enriched pathways included Acute phase response signaling and LXR/RXR activation. The DNA methylation changes ranged from 1-16%, and 407 methylation sites correlated with gene expression. Among genes known to be differentially expressed in PCOS, electroacupuncture reversed the expression of 80 genes, including PPARγ and ADIPOR2. Changes in the expression of Nr4a2 and Junb are reversed by adrenergic blockers in rats demonstrating that changes in gene expression, in part, is due to activation of the sympathetic nervous system. In conclusion, low-frequency electroacupuncture with muscle contractions remodels epigenetic and transcriptional changes that elicit metabolic improvement.Entities:
Mesh:
Year: 2018 PMID: 29382850 PMCID: PMC5790004 DOI: 10.1038/s41598-017-17919-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Circulating and adipose tissue concentrations of sex steroids measured by GC-MS/MS in women with PCOS and controls pair-wise matched for age, body weight, and body mass index.
| Variable | Controls ( | PCOS ( | |
|---|---|---|---|
| Age (years) | 29.76 ± 6.36 | 31.19 ± 5.56 | 0.520 |
| Weight (kg) | 84.64 ± 11.35 | 85.11 ± 13.60 | 0.902 |
| BMI (kg/m2) | 30.41 ± 3.62 | 31.2 ± 4.12 | 0.534 |
| Triglycerides (mmol/l) | 0.85 ± 0.31 | 1.20 ± 0.52 |
|
|
| |||
| DHEA (pg/ml) | 5599 ± 4111 | 6873 ± 3375 | 0.283 |
| DHT (pg/ml) | 75.89 ± 29.2 | 100.7 ± 32.3 |
|
| E1 (pg/ml) | 46.93 ± 16.54 | 69.48 ± 33.58 |
|
| E2 (pg/ml) | 57.35 ± 41.76 | 87.12 ± 63.16 | 0.080 |
| Progesterone (pg/ml) | 822 ± 2622 | 1186 ± 2628 | 0.672 |
|
| |||
| DHEA (pg/g) | 20238 ± 9 606 | 22381 ± 521 | 0.538 |
| DHT (pg/g) | 3461 ± 9434 | 9500 ± 28110 | 0.232 |
| E1 (pg/g) | 350.0 ± 157.8 | 521.6 ± 273.2 | 0.058 |
| E2 (pg/g) | 209.9 ± 333.2 | 161.7 ± 115.8 | 0.285 |
| Progesterone (pg/g) | 8327 ± 16809 | 10226 ± 22790 | 0.753 |
P* Fisher permutation test. DHEA, dehydroepiandrosterone; DHT, dihydrotestosterone; E1, estrone; E2, estradiol.
Figure 1Measurements of adipocyte size. Women with PCOS had larger adipocytes than controls (A). Differences in androstenedione and testosterone concentrations in circulation (B,C), and in subcutaneous adipose tissue (D,E), between women with PCOS and controls.
Figure 2Venn diagram illustrating the overlap in significant changes in gene expression caused by a single bout of electroacupuncture and significantly differently expressed genes between women with and without PCOS (Baseline)[9].
Twenty-five individual genes with the largest increase and decrease in mRNA expression in adipose tissue by a single bout of electroacupuncture in twenty-one women with PCOS (Q < 0.05).
| Gene symbol | Illumina ID | Before Single Acupuncture | After Single Acupuncture | Change (%) | ||
|---|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | |||||
|
| 1751607 | 68.2 ± 110.3 | 1709.2 ± 1094.7 | 2404.7 | 0.000 | 0.000 |
|
| 1699651 | 28.2 ± 20.7 | 542.5 ± 388.2 | 1824.3 | 0.000 | 0.000 |
|
| 2184373 | 51.7 ± 37.9 | 650.7 ± 457.8 | 1158.3 | 0.000 | 0.000 |
|
| 1748751 | 33.7 ± 10.8 | 405.9 ± 265.2 | 1104.6 | 0.000 | 0.000 |
|
| 3248551 | 34.5 ± 10.6 | 406.2 ± 242.3 | 1075.8 | 0.000 | 0.000 |
|
| 2188264 | 202 ± 162.8 | 2259.3 ± 1083.5 | 1018.5 | 0.000 | 0.000 |
|
| 1739393 | 23.7 ± 3.3 | 263 ± 217.8 | 1007.5 | 0.000 | 0.000 |
|
| 1782305 | 50.5 ± 17.7 | 543.3 ± 416.6 | 976.8 | 0.000 | 0.000 |
|
| 1682636 | 27.4 ± 9.6 | 288.9 ± 164.1 | 952.4 | 0.000 | 0.000 |
|
| 1781001 | 31.6 ± 15.3 | 307.3 ± 185.8 | 873.5 | 0.000 | 0.000 |
|
| 1762899 | 189.2 ± 231.7 | 1756.5 ± 828.5 | 828.3 | 0.000 | 0.000 |
|
| 1720048 | 327.6 ± 423.7 | 2608 ± 1484.5 | 696.0 | 0.000 | 0.000 |
|
| 2374865 | 88.3 ± 67.3 | 688.5 ± 344 | 680.0 | 0.000 | 0.000 |
|
| 2054297 | 42.6 ± 32.5 | 322.9 ± 225.2 | 657.4 | 0.000 | 0.000 |
|
| 1669523 | 193.5 ± 195.9 | 1411.2 ± 914.7 | 629.1 | 0.000 | 0.000 |
|
| 1775708 | 273.3 ± 144.5 | 1843.7 ± 898.2 | 574.7 | 0.000 | 0.000 |
|
| 1673566 | 179.4 ± 58.3 | 1058.5 ± 478.8 | 490.0 | 0.000 | 0.000 |
|
| 1743199 | 55.3 ± 27.2 | 313.5 ± 175.3 | 466.4 | 0.000 | 0.000 |
|
| 2110908 | 102.2 ± 48.4 | 543.5 ± 272.9 | 431.5 | 0.000 | 0.000 |
|
| 2086077 | 53.3 ± 20.9 | 282.9 ± 150.8 | 430.5 | 0.000 | 0.000 |
|
| 1723522 | 216.4 ± 82.9 | 1147.4 ± 553.1 | 430.2 | 0.000 | 0.000 |
|
| 1741021 | 32.3 ± 11.1 | 169.3 ± 99.3 | 424.8 | 0.000 | 0.000 |
|
| 1712112 | 48 ± 21.4 | 249.5 ± 177.5 | 419.6 | 0.000 | 0.000 |
|
| 1677402 | 318.7 ± 178.2 | 1645.7 ± 755.3 | 416.4 | 0.000 | 0.000 |
|
| 1722781 | 24.2 ± 5 | 123.3 ± 63.4 | 410.0 | 0.000 | 0.000 |
|
| 3269484 | 369 ± 150.7 | 170.8 ± 53.8 | −53.7 | 0.000 | 0.000 |
|
| 1708041 | 251.7 ± 93.7 | 124.2 ± 41 | −50.7 | 0.000 | 0.000 |
|
| 2402817 | 426.3 ± 175.4 | 225.6 ± 93.8 | −47.1 | 0.000 | 0.000 |
|
| 1811790 | 58.6 ± 17.7 | 32.4 ± 10.2 | −44.8 | 0.000 | 0.000 |
|
| 1659990 | 468.8 ± 170.5 | 281 ± 76.9 | −40.1 | 0.000 | 0.000 |
|
| 1795063 | 124.3 ± 49.8 | 76.6 ± 24.2 | −38.4 | 0.000 | 0.001 |
|
| 1661599 | 942.8 ± 359.6 | 580.9 ± 196 | −38.4 | 0.000 | 0.000 |
|
| 1793543 | 42.7 ± 13.3 | 26.6 ± 6.4 | −37.7 | 0.000 | 0.000 |
|
| 1719986 | 468.1 ± 103.2 | 296.1 ± 75.3 | −36.7 | 0.000 | 0.000 |
|
| 1715555 | 177.6 ± 50.3 | 113.4 ± 27.5 | −36.1 | 0.000 | 0.000 |
|
| 1660847 | 593.2 ± 279.6 | 382.7 ± 125.9 | −35.5 | 0.000 | 0.003 |
|
| 1724480 | 361.7 ± 134.9 | 235.5 ± 73.9 | −34.9 | 0.000 | 0.000 |
|
| 2203891 | 212.4 ± 83.4 | 138.5 ± 44 | −34.8 | 0.000 | 0.000 |
|
| 1690454 | 119.7 ± 27.4 | 79.1 ± 16.8 | −33.9 | 0.000 | 0.000 |
|
| 2401253 | 92.2 ± 55.9 | 61 ± 20 | −33.8 | 0.000 | 0.000 |
|
| 1815114 | 72.7 ± 22.6 | 48.2 ± 7.7 | −33.7 | 0.000 | 0.000 |
|
| 1740502 | 56.5 ± 17.4 | 37.8 ± 18 | −33.2 | 0.000 | 0.002 |
|
| 1776678 | 1084.7 ± 280.5 | 737.5 ± 175.4 | −32.0 | 0.000 | 0.000 |
|
| 1706511 | 308.8 ± 57.7 | 210.1 ± 54.8 | −32.0 | 0.000 | 0.000 |
|
| 2371055 | 733.5 ± 162.1 | 504.1 ± 89.9 | −31.3 | 0.000 | 0.000 |
|
| 1684982 | 792.3 ± 201 | 546.5 ± 216.5 | −31.0 | 0.000 | 0.000 |
|
| 1736670 | 582.3 ± 336.9 | 404.8 ± 213.8 | −30.5 | 0.000 | 0.004 |
|
| 1722206 | 107.7 ± 30.6 | 75.3 ± 29.3 | −30.1 | 0.000 | 0.001 |
|
| 1718898 | 158.4 ± 31.8 | 110.8 ± 18.8 | −30.0 | 0.000 | 0.000 |
|
| 1658080 | 144.5 ± 36 | 101.4 ± 26.4 | −29.8 | 0.000 | 0.003 |
Figure 3Effect of a single bout of electroacupuncture on genes with the largest changes in mRNA expression. (A) The largest expression changes in genes with increased mRNA levels and (B) The largest expression changes in genes with decreased mRNA levels relevant to PCOS. Values for gene expression are Mean ± SD. Q < 0.05. (C) Differential DNA methylation sites corresponding to genes with the largest increase in expression and (D) differential methylation sites for genes with the largest decrease in expression. Values are Mean ± SD. Q = 0.11.
Significant gene sets with changed gene expression in adipose tissue from before to after a single bout of electroacupuncture in women with PCOS after Benjamin- Hochberg p-value correction for multiple testing. Ingenuity Pathway Analysis analyses with Q < 0.05.
| Pathway | Regulated/Total | Ratio | Z-score | Signaling Pathway Category | Top Functions & Diseases | |
|---|---|---|---|---|---|---|
|
| ||||||
| Acute Phase Response Signaling | 32/103 | 0.311 | 2.043 | 1.36E-5 | Cytokine Signaling; Ingenuity Toxicity List Pathways | Cellular Movement; Hematological System Development and Function Immune Cell Trafficking |
| TREM1 Signaling | 17/40 | 0.425 | 3.638 | 1.66E-5 | Cellular Immune Response; Cytokine Signaling | Cell-To-Cell Signaling and Interaction; Hematological System Development and Function; Immune Cell Trafficking |
| Leukocyte Extravasation Signaling | 36/123 | 0.293 | 4.004 | 1.78E-5 | Cellular Immune Response | Cellular Movement; Cell-To-Cell Signaling and Interaction; Hematological System Development and Function |
| IL-6 Signaling | 27/85 | 0.318 | 3.53 | 4.08E-5 | Cellular Immune Response; Cytokine Signaling | Cellular Development; Cellular Growth and Proliferation; Hematological System Development and Function |
| Production of NO and ROS in Macrophages | 34/119 | 0.286 | 3.182 | 5.21E-5 | Cellular Immune Response | Cell Signaling; Small Molecule Biochemistry; Free Radical Scavenging |
| Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes | 22/65 | 0.338 | 3.838 | 7.16E-5 | Cellular Immune Response | Inflammatory Response; Cellular Function and Maintenance; Cell-To-Cell Signaling and Interaction |
| Protein Kinase A Signaling | 49/205 | 0.239 | 0.493 | 2.14E-4 | Intracellular and Second Messenger Signaling | Cellular Growth and Proliferation; Tissue Development; Tissue Morphology |
| NRF2-mediated Oxidative Stress Response | 33/123 | 0.268 | 2.5 | 2.50E-4 | Cellular Stress and Injury | Cell Death and Survival; Organismal Survival; Post- Translational Modification |
| MIF Regulation of Innate Immunity | 11/25 | 0.44 | 2.714 | 3.67E-4 | Cellular Immune Response | Lipid Metabolism; Small Molecule Biochemistry; Cell-To-Cell Signaling and Interaction |
| Dendritic Cell Maturation | 27/96 | 0.281 | 4.315 | 3.96E-4 | Cellular Immune Response; Cytokine Signaling; Pathogen-Influenced Signaling | Cellular Development; Hematopoiesis; Cell-To-Cell Signaling and Interaction |
| Toll- Like Receptor Signaling | 16/47 | 0.34 | 2.714 | 6.32E-4 | Apoptosis; Cellular Immune Response; Humoral Immune Response; Pathogen-Influenced Signaling | Infectious Diseases; Organismal Injury and Abnormalities; Renal and Urological Disease |
| Prolactin Signaling | 18/57 | 0.316 | 0.943 | 8.24E-4 | Cytokine Signaling; Organismal Growth and Development | Embryonic Development; Organismal Development; Cell Death and Survival |
| MIF-mediated Glucocorticoid regulation | 9/20 | 0.45 | 2.121 | 1.04E-3 | Cellular Immune Response; Nuclear Receptor Signaling | Hematological Disease; Infectious Diseases; Organismal Injury and Abnormalities |
| Role of IL-17F in Allergic Inflammatory Airway Diseases | 9/21 | 0.429 | 3 | 1.59E-3 | Cytokine Signaling; Disease-Specific Pathways | Cell-To-Cell Signaling and Interaction; Cellular Movement; Immune Cell Trafficking |
| B Cell Receptor Signaling | 28/110 | 0.255 | 4.041 | 1.72E-3 | Humoral Immune Response | Cellular Development; Cellular Growth and Proliferation; Hematological System Development and Function |
| Aryl Hydrocarbon Receptor Signaling | 24/90 | 0.267 | 2 | 1.83E-3 | Apoptosis; Cell Cycle Regulation; Ingenuity Toxicity List Pathways; Nuclear Receptor Signaling; Xenobiotic Metabolism | Cell Cycle; Gene Expression; Cell Death and Survival |
| HMGB1 Signaling | 23/85 | 0.271 | 3.71 | 1.83E-3 | Cellular Immune Response; Cellular Stress and Injury; Cytokine Signaling; Humoral Immune Response | Cell-To-Cell Signaling and Interaction; Cellular Movement; Hematological System Development and Function |
| B-cell Activating Factor Signaling | 10/26 | 0.385 | 1.89 | 2.34E-3 | Cellular Growth, Proliferation and Development; Humoral Immune Response | Cellular Development; Cellular Growth and Proliferation; Hematological System Development and Function |
| April Mediated Signaling | 10/26 | 0,385 | 1.265 | 2.34E-3 | Apoptosis | Cellular Development; Cellular Growth and Proliferation; Hematological System Development and Function |
| Tec Kinase Signaling | 26/103 | 0.252 | 4.082 | 2.80E-3 | Intracellular and Second Messenger Signaling | Cell Death and Survival; Cell-To-Cell Signaling and Interaction; Cellular Function and Maintenance |
| Type I Diabetes Melitus Signaling | 19/68 | 0.279 | 1.698 | 2.99E-3 | Apoptosis; Disease- Specific Pathways | Cellular Development; Cellular Growth and Proliferation; Hematological System Development and Function |
| Role of NFAT in Regulation of the Immune Response | 27/109 | 0.248 | 2.985 | 3.13E-3 | Cellular Immune Response; Humoral Immune Response; Intracellular and Second Messenger Signaling | Cellular Development; Cellular Growth and Proliferation; Embryonic Development |
|
| ||||||
| LXR/RXR Activation | 24/67 | 0.358 | −3.838 | 1.51E-5 | Ingenuity Toxicity List Pathways; Nuclear Receptor Signaling | Lipid Metabolism; Molecular Transport; Small Molecule Biochemistry |
| PPAR Signaling | 21/66 | 0.318 | −2.4 | 2.78E-4 | Nuclear Receptor Signaling | Gene Expression; Cancer; Organismal Injury and Abnormalities |
Figure 4Top four gene sets activated by a single bout of electroacupuncture contributing to significant top canonical pathways, identified by Ingenuity Pathway Analysis, of possible relevance to PCOS and T2D. (A) Acute Phase Signaling Pathway, (B) TREM1 Signaling (C) LXR/RXR Activation Pathway, (D) PPARγ signaling pathway. Values are presented as Fold Change. Q < 0.05.
Figure 5Effects of a single bout of electroacupuncture on mRNA levels of transcription factors involved in the regulation of adipogenesis: Positive regulators of adipocyte development include the transcription factor AP-1 (Activator protein-1) family (A); Kruppel- like family of transcription factors (B); C/EBP transcription family (C) and Transcription factors targeting PPAR- family (D). Negative regulators of adipose cell differentiation (E). Values for gene expression are Mean ± SD. Q < 0.05.
Figure 6Gene expression quantification measurements of Nr4a2 and Junb in inguinal fat in rats. Rats were divided into two experiments receiving electroacupuncture (EA) or no stimulation (NS) and were administrated saline (S) or a combination of nonselective α and β-adrenergic blocking agents Phentolamine and Propranolol (PP). Comparisons were made between groups receiving EASS and EAPP; *indicates P < 0.05 (Mann- Whitney U test). Values are Mean ± SEM.
Figure 7Effects of a single bout of electroacupuncture on global DNA methylation in human subcutaneous adipose tissue in women with PCOS. Global DNA methylation was calculated as the average DNA methylation of all CpG sites in each annotated region on the Infinium Human Methylation 450 BeadChip presented for (A) the nearest gene region and (B) the nearest CpG island region (mean ± SD). The distribution of significant sites compared to all analyzed sites in relation to (C) the nearest gene region and (D) the nearest CpG island region. The absolute difference in DNA methylation of 17, 510 individual CpG sites in adipose tissue from 16 women with PCOS after a single bout of electroacupuncture divided into (E) sites with decreased methylation and (F) sites with increased methylation. TSS, proximal promoter defined as 200 or 1500 bp upstream of the transcription site; Shore, flanking region of CpG island (0–2000 bp from the CpG island); Shelf, regions flanking island shores (2000–4000 bp from the CpG island).
Figure 8Venn diagram illustrating (A) Overlap between changes in gene expression and DNA methylation caused by a single bout of electroacupuncture. (B) Overlapping data of significant changes according to the direction of the changes in methylation and gene expression induced by a single bout of electroacupuncture. (C) Correlations of gene expression with DNA methylation in adipose tissue after a single bout of electroacupuncture. Expression of regulatory factor X variant 2 (RFX2) gene: a transcription factor, correlates negatively with DNA methylation (cg04512965).
Correlations between changes in the glucose infusion rate and the 25 genes with the largest changes in expression (n = 21; Q < 0.05) and their corresponding methylation sites (n = 16; Q = 11) after a single bout of electroacupuncture in women with PCOS.
| Gene symbol | Illumina ID | Correlation Coefficient | Expression Significance | Target ID | Gene Region | Correlation Coefficient | Methylation Significance |
|---|---|---|---|---|---|---|---|
|
| 1740502 | −0.570 | 0.007 | cg24889914 | TSS200 | −0.703 | 0.002 |
| cg16715857 | Body | −0.524 | 0.037 | ||||
|
| 1811790 | −0.560 | 0.008 | ns | ns | ||
|
| 2133316 | −0.496 | 0.022 | ns | ns | ||
|
| 1722206 | −0.561 | 0.008 | ns | ns | ||
|
| 1660847 | 0.483 | 0.027 | cg16179674 | Body | 0.518 | 0.04 |
|
| 2203891 | 0.456 | 0.038 | ns | ns | ||
|
| 2402817 | 0.444 | 0.044 | cg20268992 | Body | 0.612 | 0.012 |
|
| 2305407 | 0.499 | 0.021 | cg04049253 | Body | 0.568 | 0.022 |
|
| ns | ns | cg16747828 | Body; TSS200 | −0.703 | 0.002 | |
|
| ns | ns | cg02952809 | TSS1500 | −0.691 | 0.003 | |
|
| ns | ns | cg04633676 | TSS1500 | −0.597 | 0.015 | |
|
| ns | ns | cg18356190 | Body | 0.500 | 0.049 | |
|
| ns | ns | cg08810842 | Body | 0.521 | 0.039 | |
|
| ns | ns | cg07082452 | 3′UTR | 0.538 | 0.031 | |
|
| ns | ns | cg03127416 | Body | 0.521 | 0.039 | |
|
| ns | ns | cg14394550 | Body | 0.544 | 0.029 | |
|
| ns | ns | cg23404711 | Body | −0.521 | 0.039 | |
|
| ns | ns | cg12542255 | Body | 0.506 | 0.046 | |
|
| ns | ns | cg18941818 | Body | 0.500 | 0.049 | |
|
| ns | ns | cg06101180 | Body | 0.509 | 0.044 | |
|
| ns | ns | cg21758126 | Body | 0.600 | 0.014 | |
|
| ns | ns | cg20570611 | Body | 0.506 | 0.046 | |
|
| ns | ns | cg09784259 | TSS1500 | −0.738 | 0.001 |